News
| 6 min read
New research on vaccines that cover multiple influenza viruses arrives frequently, but biological, evolutionary, and communications challenges remain.
| 3 min read
COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.
| 2 min read
A new oral delivery system may replace injections for people with diabetes.
| 4 min read
Scientists identified two proteins that help Lyme bacteria evade detection by the human complement system, paving the way for new therapeutics and vaccine targets.
| 3 min read
A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.
| 10+ min read
Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.
| 2 min read
Researchers simultaneously increased the potency of a cancer drug while reducing both the required dose and the side effects, all by using a surprising new drug delivery vehicle: bacteria.
| 4 min read
A novel, non-invasive treatment using electrical currents exploits physiological properties of dividing cancer cells to prolong survival and augment current therapies.
| 3 min read
Wolfram Syndrome is a rare disease that causes a myriad of challenges, including deafness, diabetes, and depression. New research suggests that an agonist used to treat neurodegenerative disorders may help alleviate some of the symptoms.
| 2 min read
What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?
| 3 min read
Scientists found that the Kisspeptin hormone activates enzymes that stop lipid formation in the mouse liver, suggesting that it has potential as a drug target for treating non-alcoholic fatty liver disease.
| 3 min read
Antibiotic resistance is on the rise and scientists are on the lookout for new therapeutics for treating human pathogens. One promising new venture repurposes antimalarial drugs to treat patients with chronic lung diseases such as cystic fibrosis.
